Tempest Therapeutics TPST
NASDAQ TPST
$0.81 -0.03 (-3.38%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) EV to CFO (2018)

Updated

Tempest Therapeutics' (TPST) EV to CFO stood at 43.52 in Q3 2018.

Analysis

Tempest Therapeutics (TPST) EV to CFO (2018) Analysis & Trends

On a TTM basis, Tempest Therapeutics' EV to CFO came in at -20.71 as of Sep 30, 2018.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tempest Therapeutics 4.09 Mn -26.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 43.52
API Access

Tempest Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TPST&period=max&api_key=YOUR_API_KEY